Home › Trial NCT00210470
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
- Trial IDNCT00210470
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorBrooklyn ImmunoTherapeutics, LLC
- Enrollment27
- Start date2005-07
- ConditionsSquamous Cell Carcinoma of the Head and Neck
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.